One of the anti-vaxx or vaxx hesitant arguments is that Pharma can't be sued for damages under EUA. I'm honestly not sure how true that is precisely.
https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-c...
Claims can only go by "vaccine court" (yes that's a thing according to Wikipedia)...
https://en.wikipedia.org/wiki/National_Vaccine_Injury_Compen...
For the "vaccine court" you're just presenting a claim that vaccine X could cause condition Y, that you developed condition Y after taking vaccine X, and that there's no other reason you'd suffer from condition Y. If the court finds it plausible, you (and your lawyers) get paid, and everyone goes about their business the same as before.
> "NCLA is pleased that GMU granted Professor Zywicki’s medical exemption, which we believe it only did because he filed this lawsuit. According to GMU, with the medical exemption, Prof. Zywicki may continue serving the GMU community, as he has for more than two decades, without receiving a medically unnecessary vaccine and without undue burden. Nevertheless, NCLA remains dismayed by GMU’s refusal—along with many other public and private universities and other employers—to recognize that the science establishes beyond any doubt that natural immunity is as robust or more so than vaccine immunity.”
https://www.federalregister.gov/documents/2020/03/17/2020-05...
The Secretary must also state that liability protections available under the PREP Act are in effect with respect to the Recommended Activities. These liability protections provide that, “[s]ubject to other provisions of [the PREP Act], a covered person shall be immune from suit and liability under federal and state law with respect to all claims for loss caused by, arising out of, relating to, or resulting from the administration to or use by an individual of a covered countermeasure if a Declaration has been issued with respect to such countermeasure.”
...
The PREP Act states that a “Covered Countermeasure” must be a “qualified pandemic or epidemic product,” or a “security countermeasure,” as described immediately below; or a drug, biological product or device authorized for emergency use in accordance with Sections 564, 564A, or 564B of the FD&C Act.